BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11042523)

  • 1. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells.
    Kojima H; Bai A; Mukai HY; Hori M; Komeno T; Hasegawa Y; Ninomiya H; Mori N; Nagasawa T
    Leuk Lymphoma; 2000 May; 37(5-6):617-21. PubMed ID: 11042523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
    Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute undifferentiated leukemia with an unusual CD7+ CD56+ CD33+ immunophenotype of NK progenitors.
    Reuss-Borst MA; Jaschonek K; Müller CA
    Leukemia; 1996 May; 10(5):923-4. PubMed ID: 8656693
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
    Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
    Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
    Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells.
    Handgretinger R; Schäfer HJ; Baur F; Frank D; Ottenlinger C; Bühring HJ; Niethammer D
    Immunol Lett; 1993 Aug; 37(2-3):223-8. PubMed ID: 7505004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a lymphotropic nature of circulating plasmacytoid monocytes: findings from a case of CD56+ chronic myelomonocytic leukemia.
    Horny HP; Kaiserling E; Handgretinger R; Ruck P; Frank D; Weber R; Jaschonek KG; Waller HD
    Eur J Haematol; 1995 Apr; 54(4):209-16. PubMed ID: 7540556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
    Milush JM; Long BR; Snyder-Cappione JE; Cappione AJ; York VA; Ndhlovu LC; Lanier LL; Michaëlsson J; Nixon DF
    Blood; 2009 Nov; 114(23):4823-31. PubMed ID: 19805616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
    Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
    Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hematodermic CD4/CD56 neoplasm].
    Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
    Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression.
    Sojitra P; Gandhi P; Fitting P; Kini AR; Alkan S; Velankar MM; Venkataraman G
    Am J Clin Pathol; 2013 Nov; 140(5):686-92. PubMed ID: 24124148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.
    Anargyrou K; Paterakis G; Boutsis D; Politou M; Papadhimitriou SI; Siakandaris M; Vassiliadis J; Androulakis A; Meletis J; Rombos J; Tassiopoulou A; Vaiopoulos G
    Eur J Haematol; 2003 Oct; 71(4):294-8. PubMed ID: 12950240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
    Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
    Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
    Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
    Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+, CD33-, CD13-, CD14- acute monoblastic leukaemia.
    Lombard EH; Mansvelt EP
    Acta Haematol; 1992; 87(3):151-2. PubMed ID: 1379402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.
    Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D
    Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.